-
1. ARTICLE
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial
- 저자
- by Shi, Lei a, b, 1; Yuan, Xin a, b, 1; Yao, Weiqi c, d, 1; Wang, Siyu a, 1; Zhang, Chao a, b; Zhang, Bo e; Song, Jinwen a, b; Huang, Lei a, b; Xu, Zhe a, b; Fu, Jun-Liang a, b; Li, Yuanyuan a; Xu, Ruonan a; Li, Tian-Tian a, f; Dong, Jinghui g; Cai, Jianming g; Li, Genshi h; Xie, Yunbo a; Shi, Ming a; Li, Yonggang a; Zhang, Yu d, i; Xie, Wei-Fen j, k, ⁎; Wang, Fu-Sheng a, b, ⁎⁎
- 소스
- In eBioMedicine January 2022 75